Hirakata, Japan

Fumihiko Akahoshi

This inventor holds 3 USPTO granted patents. Top assignees: The Green Cross Corporation, Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumihiko Akahoshi. Retrieved from https://idiyas.com/inventor/fumihiko-akahoshi-p2imrb2s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.2

ph-index = 3

Forward Citations = 66(Granted Patents)


Location History:

  • Osaka, JP (1998)
  • Hirakata, JP (1999 - 2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fumihiko Akahoshi: Innovator in Heterocyclic Amide Compounds

Introduction

Fumihiko Akahoshi is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic amide compounds. With a total of 3 patents to his name, Akahoshi's work has implications for pharmaceutical applications.

Latest Patents

Akahoshi's latest patents include innovative research on heterocyclic amide compounds and their medicinal uses. His patents focus on the pharmaceutical applications of these compounds, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Fumihiko Akahoshi has worked with prominent companies in the pharmaceutical industry. He has been associated with The Green Cross Corporation and Yoshitomi Pharmaceutical Industries, Ltd., where he has contributed to various research initiatives.

Collaborations

Akahoshi has collaborated with esteemed colleagues, including Atsuyuki Ashimori and Takuya Yoshimura. These partnerships have further enriched his research and development efforts in the field.

Conclusion

Fumihiko Akahoshi's contributions to the field of medicinal chemistry through his patents on heterocyclic amide compounds highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…